Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Earnings Watch For Jan 29 (DHI, LLY, F, PFE, BSX, BRCM)

Pfizer Inc. (PFE: Quote) is due to post its fourth quarter results. The pharmaceutical giant is expected to post earnings of $0.44 per share, lower than the year-ago quarter's $0.50 per share. Also, quarterly revenues are anticipated to decline to $14.37 billion from $16.75 billion in the prior-year quarter. PFE closed Monday at $26.84. (52-wk H/L $27.30/$20.75)

DR Horton Inc. (DHI: Quote) is expected to report results for the first quarter before the markets open. The earnings of the homebuilder are expected to increase to $0.14 per share from $0.09 per share reported a year earlier. Quarterly revenues are estimated to grow to $1.10 billion from last year's $884.30 million. On Monday, the stock closed at $21.31. (52-wk H/L $22.79/$13.45)

Drugmaker Eli Lilly & Co. (LLY: Quote) is also scheduled to report fourth quarter results before the start of trading. The Indianapolis, Indiana-based company's earnings are expected to decline to $0.78 per share from $0.87 per share reported a year earlier. Quarterly revenues are anticipated to fall to $5.81 billion from last year's $6.05 billion. The company's shares closed Monday's session at $52.64. (52-wk H/L $53.99/$38.30)

Automaker Ford Motor Co. (F: Quote) is slated to report results for the fourth quarter. Earnings and revenue for the quarter are expected to be $0.25 per share and $32.94 billion respectively. In the previous year, the Dearborn, Michigan-based company posted earnings of $0.20 per share on revenues of $32.60 billion. The stock closed Monday at $13.78. (52-wk H/L $14.30/$8.82)

Boston Scientific Corp. (BSX: Quote) will report its fourth-quarter results today. The company is expected to post earnings of $0.11 per share, up from $0.08 per share reported a year earlier, while quarterly revenues are anticipated to decline to $1.76 billion from last year's $1.85 billion. The company's shares closed Monday's session at $6.86. (52-wk H/L $6.93/$4.79)

Chipmaker Broadcom Corp. (BRCM: Quote) is expected to post fourth quarter results after the markets close. The company is expected to earn $0.73 per share, higher than the prior year's $0.68 per share on revenues of $2.07 billion. The company's shares closed Monday's regular trading at $34.06. (52-wk H/L $39.66/$28.60)

Ashland Inc. (ASH: Quote), CIT Group Inc. (CIT: Quote), Corning Inc. (GLW: Quote), Danaher Corp. (DHR: Quote), EMC Corporation (EMC: Quote), Harley-Davidson, Inc. (HOG: Quote), Illinois Tool Works Inc. (ITW: Quote), Kulicke and Soffa Industries, Inc. (KLIC: Quote), Lexmark International Inc. (LXK: Quote), Nucor Corporation (NUE: Quote), Peabody Energy Corp. (BTU: Quote), Tupperware Brands Corporation (TUP: Quote), United States Steel Corp. (X: Quote), Tyco International Ltd. (TYC: Quote), Valero Energy Corporation (VLO: Quote), ACE Limited (ACE: Quote), Arthur J Gallagher & Co. (AJG: Quote), Boston Properties Inc. (BXP: Quote), Dolby Laboratories, Inc. (DLB: Quote), Freescale Semiconductor, Ltd. (FSL: Quote), Hutchinson Technology Inc. (HTCH: Quote), Manhattan Associates, Inc. (MANH: Quote), PAREXEL International Corporation (PRXL: Quote), Spansion Inc. (CODE: Quote), Unisys Corporation (UIS: Quote) and Websense, Inc. (WBSN: Quote) are also slated to report their results.

Register
To receive FREE breaking news email alerts for Pfizer Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. (TM, TYT.L) Thursday announced 1.1 percent decline in worldwide production for October, as there was a sharp decline in production of passenger cars in Japan. Production outside Japan improved 2.3 percent. In a separate announcement, the Japanese automaker said it will recall more... Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.